Alpha DNA Investment Management’s American Express AXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-7,956
Closed -$1.84M 202
2024
Q2
$1.84M Sell
7,956
-430
-5% -$99.6K 0.72% 32
2024
Q1
$1.91M Buy
+8,386
New +$1.74M 0.71% 30

Other funds holding AXP

Alpha DNA Investment Management's AXP Position: Q3 2024 in Review

Alpha DNA Investment Management sold out of American Express (AXP) in Q3 2024, closing a stake of 7,956 shares — an estimated $1.84M sold.

Alpha DNA Investment Management first reported a position in AXP in Q1 2024 and held it in 2 quarters. The position peaked at $1.91M in Q1 2024. 2,450 funds tracked by Wall St. Rank hold AXP as of Q3 2024.

  • Alpha DNA Investment Management reported no remaining American Express position as of Q3 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 7,956 American Express shares in Q3 2024, an estimated $1.84M.
  • Alpha DNA Investment Management first reported a position in American Express in Q1 2024 and held it in 2 quarters.
  • Alpha DNA Investment Management's American Express position peaked at $1.91M in Q1 2024.
  • 2,450 funds tracked by Wall St. Rank held American Express as of Q3 2024.

Based on Alpha DNA Investment Management's 13F filing for Q3 2024, filed 12 Nov 2024.